Vigil Neuroscience, Inc. - stock earnings
VIGL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -20.5 million USD | ? USD |
| 2023Q2 | -20.2 million USD | ? USD |
| 2023Q1 | -18.8 million USD | ? USD |
| 2022Q4 | 14.3 million USD | ? USD |
| 2022Q3 | -17.4 million USD | ? USD |
| 2022Q2 | -17.0 million USD | ? USD |
| 2022Q1 | -15.3 million USD | ? USD |
| 2021Q4 | -13.0 million USD | ? USD |
| 2021Q3 | -10.7 million USD | ? USD |
| 2021Q2 | -11.4 million USD | ? USD |
| 2021Q1 | -8.2 million USD | ? USD |
| 2020Q4 | -4.2 million USD | ? USD |
| 2020Q3 | -24.3 million USD | ? USD |
VIGL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -78.9 million USD | ? USD |
| 2022 | -67.7 million USD | ? USD |
| 2021 | -43.3 million USD | ? USD |
| 2020 | -28.5 million USD | ? USD |
VIGL
Price: $2.75
52 week price:
Earnings Per Share: -2.13 USD
P/E Ratio: -1.45
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 7969
Market Capitalization: 122.1 million